Arnoletti, J. P., Frolov, A., Eloubeidi, M., Keene, K., Posey, J., Wood, T., . . . Vickers, S. M. (2010). A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer.
Παραπομπή Chicago StyleArnoletti, J. P., et al. A Phase I Study Evaluating the Role of the Anti-epidermal Growth Factor Receptor (EGFR) Antibody Cetuximab As a Radiosensitizer With Chemoradiation for Locally Advanced Pancreatic Cancer. 2010.
Παραπομπή MLAArnoletti, J. P., et al. A Phase I Study Evaluating the Role of the Anti-epidermal Growth Factor Receptor (EGFR) Antibody Cetuximab As a Radiosensitizer With Chemoradiation for Locally Advanced Pancreatic Cancer. 2010.